In other countries
The same active substances on other registers, the same brand first.
- BlenrepBrazil · Glaxosmithkline Brasil LtdaSame brand
- BlenrepCanada · 70 MG / VIAL · Powder For Solution · Glaxosmithkline INCSame brand
- BlenrepCanada · 100 MG / VIAL · Powder For Solution · Glaxosmithkline INCSame brand
- Blenrep 100 MG Polvo Para Concentrado Para Solucion Para PerfusionSpain · 110 mg · polvo para concentrado para solución para perfusión · Glaxosmithkline Trading Services LimitedSame brand
- Blenrep 70 MG Polvo Para Concentrado Para Solucion Para PerfusionSpain · 77 mg · polvo para concentrado para solución para perfusión · Glaxosmithkline Trading Services LimitedSame brand
- Blenrep 100 MG Polvo Para Concentrado Para Solucion Para PerfusionSpain · 100 mg · polvo para concentrado para solución para perfusión · Glaxosmithkline (Ireland) LimitedSame brand
- BlenrepEuropean Union · GlaxoSmithKline Trading Services LimitedSame brand
- BlenrepEuropean Union · GlaxoSmithKline Trading Services LimitedSame brand
- BlenrepItaly · Polvere per concentrato per soluzione per infusione · Glaxosmithkline Trading Services LimitedSame brand
- Blenrep 100 mg poeder voor concentraat voor oplossing voor infusieNetherlands · Poeder voor concentraat voor oplossing voor infusie · GlaxoSmithKline Trading Services LimitedSame brand
- Blenrep 70 mg poeder voor concentraat voor oplossing voor infusieNetherlands · Poeder voor concentraat voor oplossing voor infusie · GlaxoSmithKline Trading Services LimitedSame brand
- BlenrepUnited States · 70MG · injectable · Glaxosmithkline LLCSame brand
- BlenrepUnited States · 100MG · For Injection · GlaxoSmithKline Intellectual Property Development Ltd. EnglandSame brand
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
HALMED — Agencija za lijekove i medicinske proizvode RH
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH NN 67/2017 · Added 8 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Belantamab mafodotin
- Register
- Croatia (HALMED)
- Status
- Authorised
- Registration
- 17819
- ATC code
- L01FX15
- Procedure
- EU centralised
- Supply
- na recept; u ljekarni